Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.96 Insider Own21.06% Shs Outstand45.98M Perf Week0.31%
Market Cap39.57M Forward P/E- EPS next Y-0.73 Insider Trans0.00% Shs Float19.10M Perf Month10.47%
Income-23.96M PEG- EPS next Q-0.13 Inst Own62.75% Short Float0.11% Perf Quarter17.63%
Sales81.76M P/S0.48 EPS this Y45.79% Inst Trans- Short Ratio0.26 Perf Half Y54.25%
Book/sh-0.45 P/B- EPS next Y-47.30% ROA-28.02% Short Interest0.02M Perf Year-58.75%
Cash/sh1.67 P/C0.98 EPS next 5Y- ROE- 52W Range0.88 - 4.30 Perf YTD0.93%
Dividend Est.- P/FCF- EPS past 5Y-29.97% ROI-78.83% 52W High-61.98% Beta1.34
Dividend TTM- Quick Ratio1.21 Sales past 5Y13.27% Gross Margin71.93% 52W Low85.80% ATR (14)0.14
Dividend Ex-Date- Current Ratio1.34 EPS Y/Y TTM51.73% Oper. Margin-11.26% RSI (14)47.56 Volatility6.08% 8.01%
Employees114 Debt/Eq- Sales Y/Y TTM2.13% Profit Margin-29.30% Recom1.40 Target Price5.18
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q75.58% Payout- Rel Volume0.48 Prev Close1.61
Sales Surprise0.76% EPS Surprise73.92% Sales Q/Q9.48% EarningsFeb 21 BMO Avg Volume82.60K Price1.63
SMA20-0.05% SMA50-4.82% SMA200-24.81% Trades Volume40,034 Change1.55%
Date Action Analyst Rating Change Price Target Change
Nov-17-22Initiated Cantor Fitzgerald Overweight $9
Jul-29-21Downgrade Canaccord Genuity Buy → Hold $8 → $3
Feb-21-24 08:45AM
Feb-20-24 07:30AM
Feb-15-24 07:30AM
Feb-06-24 07:30AM
07:00AM Loading…
Jan-24-24 07:00AM
Jan-23-24 07:30AM
Jan-02-24 07:30AM
Dec-21-23 04:09PM
Dec-19-23 05:08AM
Dec-13-23 07:30AM
Nov-24-23 07:30AM
Oct-31-23 12:34PM
Oct-26-23 09:11AM
04:13PM Loading…
Oct-25-23 04:13PM
Oct-24-23 07:00AM
Oct-19-23 07:30AM
Oct-16-23 07:30AM
Oct-13-23 07:30AM
Oct-12-23 07:30AM
Oct-04-23 07:30AM
Sep-26-23 07:47AM
Sep-25-23 07:30AM
Sep-20-23 07:00AM
Sep-18-23 04:15PM
Sep-07-23 01:57PM
07:00AM Loading…
Sep-05-23 07:00AM
Aug-30-23 10:34AM
Aug-21-23 03:24PM
Aug-05-23 03:30PM
Jul-31-23 07:00AM
Jul-28-23 04:44PM
Jul-21-23 07:00AM
Jul-20-23 07:00AM
Jul-19-23 08:54AM
Jul-12-23 08:13AM
Jun-29-23 07:30AM
Jun-22-23 07:30AM
Jun-12-23 07:30AM
Jun-02-23 12:15PM
May-25-23 05:31PM
May-19-23 05:11PM
May-09-23 12:01PM
May-04-23 07:30AM
Apr-18-23 03:43PM
Apr-12-23 08:36AM
Apr-03-23 07:30AM
Mar-14-23 06:42PM
Mar-07-23 06:00AM
Mar-02-23 05:14AM
Feb-28-23 07:30AM
Feb-22-23 05:30PM
Feb-16-23 07:30AM
Feb-14-23 05:00PM
Jan-04-23 07:45AM
Dec-23-22 10:10AM
Dec-01-22 06:30PM
Nov-17-22 02:09PM
Oct-26-22 07:30AM
Oct-18-22 09:03AM
Oct-13-22 07:30AM
Oct-12-22 07:30AM
Oct-03-22 03:09PM
Sep-26-22 07:30AM
Sep-19-22 04:15PM
Sep-12-22 07:30AM
Aug-02-22 07:30AM
Jul-28-22 11:19AM
Jul-27-22 06:47PM
Jul-16-22 10:33AM
Jul-14-22 12:10PM
Jul-13-22 07:40AM
Jul-12-22 07:30AM
Jul-07-22 07:30AM
May-31-22 07:32AM
May-10-22 10:48AM
Apr-29-22 01:24PM
Apr-27-22 07:30AM
Apr-25-22 04:16PM
Apr-13-22 07:30AM
Apr-08-22 01:00PM
Mar-31-22 05:05PM
Mar-08-22 04:31PM
Feb-24-22 07:30AM
Feb-16-22 07:30AM
Feb-15-22 07:30AM
Feb-10-22 07:00AM
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada.